kabutan

Oenon Holdings, Inc.(2533) Summary

2533
TSE Prime
Oenon Holdings, Inc.
518
JPY
-14
(-2.63%)
Dec 5, 3:02 pm JST
3.35
USD
Dec 5, 1:02 am EST
Result
PTS
outside of trading hours
517.5
Dec 5, 3:02 pm JST
Summary Chart Historical News Financial Result
PER
10.0
PBR
1.16
Yield
1.93%
Margin Trading Ratio
0.42
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
529 JPY 3.41 USD
Previous Close Dec 4
532 JPY 3.42 USD
High Dec 5, 9:00 am
529 JPY 3.41 USD
Low Dec 5, 12:34 pm
517 JPY 3.33 USD
Volume
67,000
Trading Value
0.04B JPY 0.23M USD
VWAP
523.8 JPY 3.39 USD
Minimum Trading Value
51,800 JPY 335 USD
Market Cap
0.03T JPY 0.22B USD
Number of Trades
135
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
227
1-Year High Dec 24, 2024
1,339
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 87,400 111,000 1.27
Nov 21, 2025 91,300 88,300 0.97
Nov 14, 2025 88,800 87,800 0.99
Nov 7, 2025 76,800 109,800 1.43
Oct 31, 2025 59,700 94,100 1.58
Company Profile
Oenon Holdings, Inc. is a major producer of shochu and sake. The company is experiencing growth in its enzyme-based pharmaceutical products and is actively engaged in manufacturing private label products for mass retailers.
Sector
Foods
Oenon Holdings, Inc. manufactures and sells a wide range of alcoholic beverages, including shochu, chu-hai, sake, synthetic sake, plum wine, and Western-style liquors. While focusing on the alcoholic beverage business, the company also operates in enzyme-based pharmaceuticals and real estate. In the alcoholic beverage sector, group companies handle everything from manufacturing to sales, transportation, and cargo handling. The enzyme-based pharmaceutical business involves the sale of enzymes and diagnostic reagents, as well as fermentation contract services. The real estate division manages property sales and leasing. Additionally, the company engages in warehousing and stevedoring operations. Oenon Holdings, Inc. efficiently manages its group-wide operations, pursuing a diversified business strategy.